Equity Method Investment (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 27, 2024	Sep. 10, 2024	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Ownership shares value				$ 284		$ 977	$ 1,166
Gain on deconsolidation				$ 72,287		$ 72,287
Intellectual Property [Member]
Assignment fee	$ 350
Common Stock [Member]
Ownership shares issues				294,003		627,302	155,384
Ownership shares value
Common Stock [Member] | Lucid Diagnostics Inc [Member]
The fair value of common price per shares		40.00%	40.00%	40.00%		40.00%
Lucid Diagnostics Inc [Member]
Ownership shares issues		31,302,444
Ownership shares value		$ 25,100
Gain on deconsolidation				$ 72,300		$ 72,287
Fair value of the companys investment		$ 25,100	$ 25,500	25,500		25,500
Unrealized gain loss on investments				400		400
Lucid Diagnostics Inc [Member] | Management Services Agreement [Member] | Board of Directors Chairman [Member]
Fee income			$ 700			$ 833
Increase in fee income				$ 1,050
Lucid Diagnostics Inc [Member] | Common Stock [Member]
The fair value of common price per shares		$ 0.802	$ 0.815	$ 0.815		$ 0.815
Lucid Diagnostics Inc [Member] | Maximum [Member]
Equity method investment, ownership percentage		50.00%	50.00%	50.00%		50.00%